relative amplitude RA actigraphy
Selected indexed studies
- Circadian rhythm and epilepsy: a nationally representative cross-sectional study based on actigraphy data. (Front Neurol, 2024) [PMID:39691456]
- Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial. (J Prev Alzheimers Dis, 2021) [PMID:33336219]
- Rest-activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women. (Alzheimers Dement (Amst), 2025) [PMID:40242837]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Circadian rhythm and epilepsy: a nationally representative cross-sectional study based on actigraphy data. (2024) pubmed
- Rest-activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women. (2025) pubmed
- Rest-activity rhythms in emerging adults: implications for cardiometabolic health. (2021) pubmed
- Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial. (2021) pubmed
- The optimal measurement period of actigraphy for circadian rhythm in relation to adiposity: A retrospective case-control study. (2024) pubmed
- One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in Depression. (2026) pubmed
- Association of rest-activity and light exposure rhythms with sleep quality in insomnia patients. (2020) pubmed
- Associations of rest-activity rhythm disturbances with stroke risk and post-stroke adverse outcomes. (2023) pubmed
- 24-Hour Rest-Activity Rhythm in Middle-Aged and Older Persons with Depression. (2023) pubmed
- Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011-2014. (2023) pubmed